Since our founding in 2005 as the Primary Care Diabetes Society (PCDS), the landscape of primary care diabetes management has altered fundamentally. Changes in population demographics and public health mean that the majority of people with diabetes seen in primary care will have at least one other long-term condition in addition to their diabetes (Khunti et al, 2023).
In respect to type 2 diabetes, the focus has always been on holistic care to ensure the prevention and, where required, optimal management of any diabetes-related complications, but the advent of diabetes therapies with beneficial cardiorenal and metabolic outcomes means that it has never been so relevant to avoid being purely glucocentric in diabetes care. New pharmacological agents and dietary interventions mean that significant weight loss, potentially preventing type 2 diabetes development and even inducing type 2 diabetes remission, is now an option in primary care.
Recognising these developments and the need to, where appropriate, make weight management the cornerstone of the treatment of type 2 diabetes and its associated comorbidities, the PCDS too is evolving. On 4 March 2025, and marking World Obesity Day, we are officially becoming the Primary Care Diabetes & Obesity (PCDO) Society.
Our mission remains essentially the same:
“The aim of the Society is to support primary care professionals to deliver high-quality, clinically effective care, in order to improve the lives of people living with diabetes or obesity and associated long-term conditions.”
The PCDO Society represents all healthcare professionals involved in primary care diabetes and weight management, including GPs, practice and community nurses, pharmacists, diabetes specialist nurses, dietitians and podiatrists.
In addition to its key role in providing high-quality, evidence-based education to enhance care delivery, the PCDO Society acts as a key point of contact for government and other policy-making organisations for discussions that can make vital differences to those in our care. Together as a Society, we will:
● Share best practice in delivering quality care of diabetes, obesity and associated long-term conditions.
● Be a unique voice for all healthcare professionals working in primary care intent on improving standards in the care of diabetes, obesity and associated long-term conditions.
● Show leadership at local, national and international levels, collaborating with all organisations involved in promoting optimal weight management and diabetes care across the UK and Ireland.
● Promote and participate in high-quality research and audit.
Today, the healthcare system faces a host of challenges, and the people we see have ever more complex needs. It is primary care that has the knowledge, experience and relationships to provide the holistic care that will truly help the people we are supporting. The PCDS has been assisting us in this endeavour for 20 years, and I hope you will continue on this journey with us as the PCDO Society.
Khunti K, Chudasama YV, Gregg EW et al (2023) Diabetes and multiple long-term conditions: A review of our current global health challenge. Diabetes Care46: 2092–101
Free for all UK & Ireland healthcare professionals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
Diabetes &
Primary Care
Issue:
Vol:27 | No:01
PCDS is evolving: Introducing the Primary Care Diabetes & Obesity Society
Since our founding in 2005 as the Primary Care Diabetes Society (PCDS), the landscape of primary care diabetes management has altered fundamentally. Changes in population demographics and public health mean that the majority of people with diabetes seen in primary care will have at least one other long-term condition in addition to their diabetes (Khunti et al, 2023).
In respect to type 2 diabetes, the focus has always been on holistic care to ensure the prevention and, where required, optimal management of any diabetes-related complications, but the advent of diabetes therapies with beneficial cardiorenal and metabolic outcomes means that it has never been so relevant to avoid being purely glucocentric in diabetes care. New pharmacological agents and dietary interventions mean that significant weight loss, potentially preventing type 2 diabetes development and even inducing type 2 diabetes remission, is now an option in primary care.
Recognising these developments and the need to, where appropriate, make weight management the cornerstone of the treatment of type 2 diabetes and its associated comorbidities, the PCDS too is evolving. On 4 March 2025, and marking World Obesity Day, we are officially becoming the Primary Care Diabetes & Obesity (PCDO) Society.
Our mission remains essentially the same:
“The aim of the Society is to support primary care professionals to deliver high-quality, clinically effective care, in order to improve the lives of people living with diabetes or obesity and associated long-term conditions.”
The PCDO Society represents all healthcare professionals involved in primary care diabetes and weight management, including GPs, practice and community nurses, pharmacists, diabetes specialist nurses, dietitians and podiatrists.
In addition to its key role in providing high-quality, evidence-based education to enhance care delivery, the PCDO Society acts as a key point of contact for government and other policy-making organisations for discussions that can make vital differences to those in our care. Together as a Society, we will:
● Share best practice in delivering quality care of diabetes, obesity and associated long-term conditions.
● Be a unique voice for all healthcare professionals working in primary care intent on improving standards in the care of diabetes, obesity and associated long-term conditions.
● Show leadership at local, national and international levels, collaborating with all organisations involved in promoting optimal weight management and diabetes care across the UK and Ireland.
● Promote and participate in high-quality research and audit.
Today, the healthcare system faces a host of challenges, and the people we see have ever more complex needs. It is primary care that has the knowledge, experience and relationships to provide the holistic care that will truly help the people we are supporting. The PCDS has been assisting us in this endeavour for 20 years, and I hope you will continue on this journey with us as the PCDO Society.
Khunti K, Chudasama YV, Gregg EW et al (2023) Diabetes and multiple long-term conditions: A review of our current global health challenge. Diabetes Care 46: 2092–101
Diabetes Distilled: Time to intensify blood pressure treatment in people with type 2 diabetes?
How to undertake a multiple long-term conditions review
Diabetes Distilled: Preserving muscle is important when using incretin mimetics for weight loss
At a glance factsheet: Diabetes and cancer
Editorial: Weight loss drug hype grows
PCDS is evolving: Introducing the Primary Care Diabetes & Obesity Society
Prescribing pearls: A guide to SGLT2 inhibitors
BPROAD study: Reducing systolic blood pressure to <120 mmHg versus <140 mmHg in people with type 2 diabetes reduces cardiovascular events.
3 Apr 2025
Delivery of holistic care to adults living with type 2 diabetes and one or more additional long-term condition.
2 Apr 2025
How to minimise loss of muscle mass when using GLP-1-based therapies for weight loss.
26 Mar 2025
The potential links between diabetes and cancer, plus practical recommendations on management of hyperglycaemia in patients undergoing cancer treatment.
19 Mar 2025